Celestia
TIA
Fundamental comparison between Celestia and Injective
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
Celestia
Coverage: 11/13 · 84%
Calculated:
Injective
Coverage: 10/13 · 74%
Calculated:
Detailed Comparison
| Metric | Celestia | Injective |
|---|---|---|
| Price | $0.442528 | $7.33 |
| Market Cap | $437.47M | $733.08M |
| 24h Volume | 34.7M | 74M |
| Rank | #114 | #86 |
| Circulating Supply | 988.6M | 100M |
| ATH | $20.85 | $52.62 |
Celestia vs Injective — Analysis
Comparison of Celestia and Injective: published market readings and a Value Score using up to 13 model components. Sourced project profiles add purpose, token role and risks where available.
Value Score Comparison
Celestia: 65.6/100; Injective: 77.6/100. No direct score comparison: data coverage differ or are unrecorded.
Market Capitalization
Injective has 1.68 times the market capitalization of Celestia. This ratio measures market size; it does not establish volatility or future returns.
Price Performance
Reported price change over 24 hours: Celestia -3.73%, Injective 1.6%. Over 7 days: Celestia -14.67%, Injective -5.19%. Missing readings are shown as —.
Distance from All-Time High
Celestia trades at 2.12% of its reported all-time high; Injective at 13.93%. This distance describes price history and is not a standalone buy signal.
Conclusion
The readings show differences in market value and model assessment. Project purpose, token rights, risks, source dates and data coverage also matter. A higher score does not predict higher returns or lower risk.